Bliss GVS Pharma Ltd
NSE:BLISSGVS

Watchlist Manager
Bliss GVS Pharma Ltd Logo
Bliss GVS Pharma Ltd
NSE:BLISSGVS
Watchlist
Price: 175.71 INR -4.05% Market Closed
Market Cap: ₹18.6B

Income Statement

Earnings Waterfall
Bliss GVS Pharma Ltd

Income Statement
Bliss GVS Pharma Ltd

Rotate your device to view
Income Statement
Currency: INR
Mar-2009 Jun-2009 Sep-2009 Dec-2009 Mar-2010 Jun-2010 Sep-2010 Dec-2010 Mar-2011 Jun-2011 Sep-2011 Dec-2011 Mar-2012 Jun-2012 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Revenue
Interest Expense
23
0
0
0
20
0
0
0
21
0
0
0
31
0
0
0
0
163
0
0
0
119
0
0
0
82
0
0
0
3
0
0
0
49
0
0
0
18
0
0
0
19
0
0
0
32
0
0
0
56
0
0
0
62
0
0
Revenue
1 330
N/A
1 391
+5%
1 486
+7%
1 558
+5%
1 689
+8%
1 806
+7%
2 016
+12%
2 030
+1%
2 188
+8%
2 306
+5%
2 428
+5%
2 554
+5%
2 671
+5%
2 788
+4%
949
-66%
2 710
+186%
4 033
+49%
5 469
+36%
5 931
+8%
5 861
-1%
6 875
+17%
4 073
-41%
4 917
+21%
5 493
+12%
5 113
-7%
3 725
-27%
3 523
-5%
3 542
+1%
3 787
+7%
8 983
+137%
9 044
+1%
8 861
-2%
8 136
-8%
6 893
-15%
6 073
-12%
5 487
-10%
5 650
+3%
5 772
+2%
6 158
+7%
6 602
+7%
7 124
+8%
7 475
+5%
7 680
+3%
7 444
-3%
7 339
-1%
7 516
+2%
7 224
-4%
7 619
+5%
7 569
-1%
7 702
+2%
7 944
+3%
8 002
+1%
8 099
+1%
8 097
0%
8 336
+3%
8 603
+3%
Gross Profit
Cost of Revenue
(749)
(766)
(799)
(823)
(961)
(1 020)
(1 123)
(1 138)
(1 353)
(1 378)
(1 487)
(1 630)
(1 655)
(1 707)
(411)
(1 365)
(1 755)
(2 968)
(3 280)
(3 198)
(4 254)
(2 351)
(2 820)
(3 372)
(2 896)
(2 322)
(2 458)
(2 700)
(3 313)
(6 593)
(6 409)
(6 301)
(5 534)
(4 459)
(3 874)
(3 127)
(3 231)
(3 371)
(3 362)
(3 610)
(3 804)
(3 992)
(3 994)
(3 892)
(3 794)
(4 085)
(3 906)
(3 945)
(3 956)
(3 925)
(3 828)
(3 980)
(4 097)
(4 250)
(4 204)
(4 236)
Gross Profit
581
N/A
625
+8%
687
+10%
735
+7%
728
-1%
787
+8%
893
+14%
891
0%
835
-6%
928
+11%
942
+1%
925
-2%
1 015
+10%
1 081
+6%
538
-50%
1 344
+150%
2 278
+69%
2 501
+10%
2 651
+6%
2 662
+0%
2 622
-2%
1 722
-34%
2 097
+22%
2 121
+1%
2 218
+5%
1 403
-37%
1 064
-24%
842
-21%
473
-44%
2 389
+405%
2 636
+10%
2 561
-3%
2 602
+2%
2 435
-6%
2 200
-10%
2 360
+7%
2 419
+2%
2 402
-1%
2 796
+16%
2 992
+7%
3 321
+11%
3 482
+5%
3 686
+6%
3 552
-4%
3 545
0%
3 431
-3%
3 319
-3%
3 674
+11%
3 613
-2%
3 777
+5%
4 115
+9%
4 021
-2%
4 001
0%
3 847
-4%
4 131
+7%
4 367
+6%
Operating Income
Operating Expenses
(224)
(261)
(301)
(322)
(273)
(294)
(330)
(334)
(303)
(349)
(341)
(361)
(346)
(369)
(219)
(648)
(1 319)
(1 053)
(1 183)
(1 193)
(1 080)
(783)
(948)
(924)
(941)
(532)
(741)
(552)
(185)
(879)
(1 071)
(1 168)
(1 323)
(1 324)
(1 403)
(1 640)
(1 660)
(1 507)
(1 751)
(1 973)
(2 343)
(2 470)
(2 635)
(3 289)
(2 413)
(2 445)
(2 495)
(2 570)
(2 572)
(2 535)
(2 778)
(3 111)
(3 236)
(2 874)
(3 102)
(3 448)
Selling, General & Administrative
(172)
0
0
0
(207)
0
0
0
(224)
0
0
0
(298)
0
0
0
0
(596)
0
0
0
(471)
0
0
0
(376)
0
0
0
(554)
(115)
(258)
(399)
(1 032)
(582)
(596)
(629)
(1 149)
(698)
(730)
(749)
(1 750)
(790)
(810)
(839)
(1 832)
(891)
(914)
(936)
(1 809)
(1 091)
(1 134)
(1 188)
(2 175)
(1 165)
(1 224)
Research & Development
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(217)
0
0
0
(142)
0
0
0
(25)
0
0
0
(143)
0
0
0
(77)
0
0
0
(104)
0
0
0
(214)
0
0
0
(218)
0
0
0
(337)
0
0
0
(293)
0
0
Depreciation & Amortization
(36)
(42)
(49)
(57)
(54)
(54)
(55)
(55)
(55)
(56)
(55)
(41)
(37)
(32)
(30)
(90)
(116)
(133)
(139)
(122)
(207)
(107)
(121)
(128)
(82)
(91)
(62)
(37)
7
(89)
(95)
(107)
(115)
(126)
(141)
(149)
(163)
(172)
(173)
(173)
(173)
(173)
(175)
(179)
(181)
(187)
(203)
(221)
(244)
(264)
(270)
(276)
(282)
(294)
(308)
(320)
Other Operating Expenses
(16)
(219)
(252)
(265)
(12)
(240)
(275)
(279)
(24)
(293)
(286)
(320)
(12)
(338)
(189)
(558)
(1 203)
(107)
(1 044)
(1 072)
(874)
(64)
(826)
(796)
(859)
(39)
(679)
(516)
(192)
(93)
(861)
(803)
(810)
(89)
(680)
(895)
(868)
(81)
(880)
(1 071)
(1 421)
(333)
(1 670)
(2 301)
(1 394)
(208)
(1 401)
(1 434)
(1 392)
(125)
(1 417)
(1 701)
(1 766)
(112)
(1 629)
(1 904)
Operating Income
356
N/A
363
+2%
386
+6%
414
+7%
456
+10%
493
+8%
563
+14%
558
-1%
533
-4%
579
+9%
600
+4%
564
-6%
670
+19%
711
+6%
319
-55%
697
+118%
960
+38%
1 449
+51%
1 469
+1%
1 469
+0%
1 542
+5%
939
-39%
1 149
+22%
1 197
+4%
1 277
+7%
871
-32%
324
-63%
290
-11%
288
-1%
1 511
+424%
1 565
+4%
1 393
-11%
1 279
-8%
1 111
-13%
796
-28%
720
-10%
759
+5%
894
+18%
1 045
+17%
1 019
-2%
977
-4%
1 012
+4%
1 050
+4%
263
-75%
1 132
+331%
987
-13%
824
-17%
1 104
+34%
1 041
-6%
1 242
+19%
1 337
+8%
910
-32%
765
-16%
973
+27%
1 029
+6%
919
-11%
Pre-Tax Income
Interest Income Expense
(22)
(24)
(26)
(23)
(14)
(21)
(19)
(21)
(16)
(24)
(28)
(29)
(10)
(41)
(51)
(97)
(115)
48
(176)
(173)
(192)
(54)
(157)
(175)
(186)
21
(34)
15
(8)
366
260
262
322
327
(64)
(57)
(55)
156
(51)
(54)
(55)
263
(55)
(67)
(69)
54
(97)
(93)
(101)
176
49
25
36
239
(118)
(110)
Non-Reccuring Items
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(342)
0
0
0
0
0
0
0
(138)
(134)
0
0
0
0
0
(736)
(738)
(736)
0
0
0
0
0
0
(292)
(292)
0
0
0
0
0
Gain/Loss on Disposition of Assets
0
0
0
0
0
0
0
0
0
0
0
0
(0)
0
0
0
0
0
0
0
0
(0)
0
0
0
5
0
0
0
(22)
0
0
0
8
0
0
0
(0)
0
0
0
1
0
0
0
4
0
0
0
3
0
0
0
0
0
0
Total Other Income
69
70
68
62
16
22
14
28
13
26
78
128
135
193
65
141
204
(15)
263
215
233
(5)
40
163
106
85
300
398
396
(35)
(42)
(162)
(128)
(17)
421
319
305
(9)
210
237
256
3
307
274
270
16
159
263
261
40
159
83
182
45
675
827
Pre-Tax Income
403
N/A
409
+2%
428
+5%
452
+6%
458
+1%
494
+8%
558
+13%
565
+1%
530
-6%
581
+10%
651
+12%
663
+2%
794
+20%
863
+9%
333
-61%
741
+123%
1 049
+42%
1 482
+41%
1 556
+5%
1 511
-3%
1 583
+5%
879
-44%
1 033
+17%
1 185
+15%
1 196
+1%
640
-47%
590
-8%
702
+19%
676
-4%
1 819
+169%
1 783
-2%
1 493
-16%
1 472
-1%
1 290
-12%
1 020
-21%
982
-4%
1 009
+3%
1 041
+3%
1 204
+16%
1 202
0%
443
-63%
542
+22%
567
+5%
470
-17%
1 333
+184%
1 061
-20%
885
-17%
1 275
+44%
1 201
-6%
1 169
-3%
1 253
+7%
1 019
-19%
983
-4%
1 256
+28%
1 587
+26%
1 636
+3%
Net Income
Tax Provision
(28)
(34)
(46)
(57)
(40)
(47)
(60)
(61)
(124)
(145)
(176)
(235)
(269)
(305)
(133)
(261)
(335)
(481)
(479)
(504)
(595)
(364)
(424)
(392)
(358)
(323)
(252)
(342)
(304)
(553)
(572)
(391)
(388)
(337)
(234)
(289)
(295)
(302)
(370)
(363)
(365)
(310)
(322)
(286)
(365)
(293)
(249)
(368)
(301)
(353)
(360)
(299)
(296)
(354)
(462)
(482)
Income from Continuing Operations
375
376
382
395
417
448
498
504
406
437
476
428
525
558
200
480
715
1 002
1 077
1 007
988
515
609
794
838
317
338
360
372
1 267
1 211
1 103
1 085
953
785
693
714
740
835
839
78
231
245
184
967
767
636
907
900
816
893
720
687
903
1 125
1 154
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(4)
(54)
(67)
(177)
(240)
(253)
(322)
(306)
(396)
(388)
(388)
(299)
(148)
(95)
(29)
(29)
(19)
(15)
(19)
20
11
(1)
(4)
(55)
(69)
(66)
(62)
(81)
(80)
(93)
(96)
(59)
(38)
(24)
(20)
(61)
(78)
(85)
(91)
(60)
(59)
(58)
Net Income (Common)
375
N/A
376
+0%
382
+2%
396
+4%
444
+12%
448
+1%
498
+11%
504
+1%
406
-19%
437
+7%
476
+9%
428
-10%
525
+23%
558
+6%
195
-65%
426
+118%
648
+52%
825
+27%
838
+2%
754
-10%
666
-12%
821
+23%
824
+0%
1 017
+23%
1 062
+4%
588
-45%
759
+29%
834
+10%
913
+9%
1 237
+36%
1 192
-4%
1 087
-9%
1 066
-2%
973
-9%
797
-18%
692
-13%
710
+3%
685
-4%
766
+12%
773
+1%
17
-98%
150
+811%
165
+10%
91
-45%
871
+858%
709
-19%
598
-16%
883
+48%
879
0%
755
-14%
815
+8%
634
-22%
596
-6%
843
+41%
1 066
+27%
1 096
+3%
EPS (Diluted)
3.63
N/A
3.65
+1%
3.7
+1%
3.78
+2%
4.3
+14%
4.33
+1%
4.82
+11%
4.88
+1%
3.94
-19%
4.23
+7%
4.61
+9%
4.15
-10%
5.09
+23%
5.42
+6%
1.89
-65%
4.12
+118%
6.27
+52%
8
+28%
10.73
+34%
12.64
+18%
10.01
-21%
7.95
-21%
13.91
+75%
14.76
+6%
12.45
-16%
5.7
-54%
7.36
+29%
8.08
+10%
8.85
+10%
11.99
+35%
11.56
-4%
10.54
-9%
10.34
-2%
9.43
-9%
7.58
-20%
6.57
-13%
6.77
+3%
6.49
-4%
7.22
+11%
7.32
+1%
0.15
-98%
1.43
+853%
1.56
+9%
0.85
-46%
8.23
+868%
6.72
-18%
5.62
-16%
8.32
+48%
8.28
0%
7.11
-14%
7.59
+7%
5.98
-21%
5.68
-5%
7.95
+40%
10.01
+26%
10.21
+2%